Your browser doesn't support javascript.
loading
Combination therapy for disseminated strongyloidiasis with associated vancomycin-resistant, linezolid-intermediate Enterococcus faecium meningitis: A case report.
Tobin, Morgan A; Dougherty, David F; Ratliff, Patrick D; Judd, W Russ.
Afiliação
  • Tobin MA; Department of Pharmacy Services, Saint Joseph Hospital, Lexington, KY, USA.
  • Dougherty DF; Lexington Infectious Disease Consultants, Saint Joseph Hospital, Lexington, KY, USA.
  • Ratliff PD; Department of Pharmacy Services, Saint Joseph Hospital, Lexington, KY, USA.
  • Judd WR; Department of Pharmacy Services, Saint Joseph Hospital, Lexington, KY, USA.
J Clin Pharm Ther ; 47(1): 121-124, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34075617
ABSTRACT
WHAT IS KNOWN AND

OBJECTIVE:

The rhabditid nematode Strongyloides stercoralis is the major causative agent of disseminated strongyloidiasis (DS). In rare cases, DS has caused enterococcal meningitis. If DS-associated vancomycin-resistant Enterococcus faecium (VRE) meningitis is suspected, combination antibiotic therapy should be considered. CASE

SUMMARY:

We present a case of a 61-year-old male who developed DS associated with vancomycin-resistant and linezolid-intermediate E. faecium meningitis after receiving corticosteroids. The VRE meningitis was treated with high-dose daptomycin 12 mg/kg, linezolid, tigecycline and quinupristin/dalfopristin. Despite negative cultures, the patient expired. WHAT IS NEW AND

CONCLUSION:

In patients with DS-associated VRE meningitis, early use of combination therapy may be warranted to improve patient outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estrongiloidíase / Meningites Bacterianas / Infecções por Bactérias Gram-Positivas / Farmacorresistência Bacteriana Múltipla / Antibacterianos Tipo de estudo: Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estrongiloidíase / Meningites Bacterianas / Infecções por Bactérias Gram-Positivas / Farmacorresistência Bacteriana Múltipla / Antibacterianos Tipo de estudo: Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article